Vectus Biosystems Limited (VBS) is developing treatments for fibrosis, including for three of the largest diseases in the fibrotic market, namely heart, kidney and liver diseases. Funds from the IPO and from two subsequent fundraisings were used predominantly to develop the Company's lead compound, VB0004, which aims to treat the hardening of functional tissue and high blood pressure.
Find out what a historical investment in Vectus Biosystems would be worth today using our VBS stock calculator.
Buying VBS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Vectus Biosystems in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in VBS
What is the ticker symbol of Vectus Biosystems?
The ticker symbol for Vectus Biosystems is VBS.
How much is one share of VBS?
One share of VBS is valued at $0.05 as of 21 November 2026.
What is the market capitalisation of Vectus Biosystems VBS?
As of 21 November 2026 Vectus Biosystems has a market cap of $3.05M.
What is the P/E ratio of VBS?
The Price to Earnings ratio of VBS is 1.71.
What is the Earnings Per Share of VBS?
The Earnings Per Share of VBS is $0.03.
What is the 52-week high for Vectus Biosystems stock?
The Vectus Biosystems 52-week high stock price is $0.22.
What is the 52-week low for Vectus Biosystems stock?
The Vectus Biosystems 52-week low stock price is $0.05.
Can I buy VBS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy VBS shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.